Oxygen Biotherapeutics Announces $6M in Net Proceeds from Exercise of Warrants
November 08, 2013 at 07:42 AM EST
Oxygen Biotherapeutics (NASDAQ: OXBT ) today announced the Company has received approximately $6 million through the exercise of 2,294,874 warrants between November 4, 2013 and November 6, 2013.
